A current appraisal of drug interactions of significance in clinical practice: Focus on antifungal therapeutic agents used in the treatment of superficial mycoses

被引：0
|
作者：
Del Rosso, JQ [1 ]
机构：
[1] Univ Las Vegas, Dept Dermatol, Las Vegas, NV USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 50卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P672
引用
收藏
页码：P172 / P172
页数：1
相关论文
共 11 条
  • [1] Systemic antifungal agents - Drug interactions of clinical significance
    Albengres, E
    Le Louet, H
    Tillement, JP
    DRUG SAFETY, 1998, 18 (02) : 83 - 97
  • [2] Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization
    Scodavolpe, Simon
    Quaranta, Sylvie
    Lacarelle, Bruno
    Solas, Caroline
    ANNALES DE BIOLOGIE CLINIQUE, 2014, 72 (04) : 391 - 404
  • [3] Clinical indications for therapeutic drug monitoring of antifungal agents. In the way for optimizing the treatment of fungal infection
    Cendejas-Bueno, Emilio
    Cuenca-Estrella, Manuel
    Gomez-Lopez, Alicia
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2014, 27 (01) : 1 - 16
  • [4] Clinical Significance of Drug Interactions in the Era of direct antiviral Agents for the Treatment of chronic Hepatitis C
    Maasoumy, B.
    Port, K.
    Markova, A.
    Serrano, B. Calle
    Sollik, L.
    Manns, M.
    Cornberg, M.
    Wedemeyer, H.
    INTERNIST, 2013, 54 : 28 - 28
  • [5] Therapeutic Drug Monitoring of Antibiotics in Critically Ill Patients: Current Practice and Future Perspectives With a Focus on Clinical Outcome
    Koch, Birgit C. P.
    Muller, Anouk E.
    Hunfeld, Nicole G. M.
    de Winter, Brenda C. M.
    Ewoldt, Tim M. J.
    Abdulla, Alan
    Endeman, Henrik
    THERAPEUTIC DRUG MONITORING, 2022, 44 (01) : 11 - 18
  • [6] Therapeutic Drug Monitoring of the Echinocandin Antifungal Agents: Is There a Role in Clinical Practice? A Position Statement of the Anti-Infective Drugs Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
    Kim, Hannah Yejin
    Baldelli, Sara
    Martson, Anne-Grete
    Stocker, Sophie
    Alffenaar, Jan-Willem
    Cattaneo, Dario
    Marriott, Deborah J. E.
    THERAPEUTIC DRUG MONITORING, 2022, 44 (01) : 198 - 214
  • [7] Experience with therapeutic drug monitoring of three antifungal agents using an LC-MS/MS method in routine clinical practice
    Yoon, S. J.
    Lee, K. H.
    Oh, J. W.
    Woo, H. I.
    Lee, S. Y.
    CLINICA CHIMICA ACTA, 2019, 493 : S73 - S74
  • [8] Experience with therapeutic drug monitoring of three antifungal agents using an LC-MS/MS method in routine clinical practice
    Yoon, Sun Joo
    Lee, Kyunghoon
    Oh, Jongwon
    Woo, Hye In
    Lee, Soo-Youn
    CLINICAL BIOCHEMISTRY, 2019, 70 : 14 - 17
  • [9] Invasive Mycoses in High-Risk Cancer Patients - a Prospective Analysis of Clinical Parameters, Side Effects, Drug Interactions and Costs for the Safe and Economically Appropriate Use of Systemic Antifungal Agents
    Neubauer, Werner
    Zerweck, Alf
    Goebel, Alexandra
    Lubrich, Beate
    Bertz, Hartmut
    Engelhardt, Monika
    BLOOD, 2009, 114 (22) : 981 - 981
  • [10] Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation
    Pirisinu, Marco
    Tin Chanh Pham
    Zhang, Daniel Xin
    Tran Nguyen Hong
    Lap Thi Nguyen
    Le, Minh T. N.
    SEMINARS IN CANCER BIOLOGY, 2022, 80 : 340 - 355
12